TRANBERG - Founder History

Our co-founder, professor Karl-Göran Tranberg, began innovative scientific research into how precise laser-generated “low temperature-long time” thermal ablation (imILT), of cancer tumors triggered the immune system to track and kill cancer cells throughout the body, the so called abscopal effect.

Through this research, CLS gained significant knowledge and experience with treating/killing prostate cancer tumors under MRI-guidance using focal laser ablation.  A number of clinical trials have been conducted and published since then; some are ongoing, and several new studies are planned for the near future.

CLS is currently conducting clinical studies on laser ablation using various image-guidance systems including MR, MR/US Fusion, and Micro-Ultrasound, for the treatment of low-to-medium risk prostate cancer. The procedure is designed to enable urologist physicians to treat patients in a urology clinic or office, and not require a hospital visit or stay. Fusion guidance is already successfully being used for targeted prostate biopsies and focal therapies.

News and insights

17 November, 2023

Customer Experience AVANT Concierge Urology

Learn about our progress within the Mobile Service Provider Model enabling more clinics to treat prostate cancer patients.

Read more
7 November, 2023

Podcast Episode with Insight from the US Market

Listen to a podcast episode with Michael Magnani, President of CLS Americas and Dr Garrett D. Pohlman, urologist at Kearney and the host of the Prostate Health Podcast. They had an engaging discussion around the key features and benefits of using the TRANBERG system for the treatment of low to intermediate localized prostate cancer.

Read more
1 August, 2023

Interview with CLS's Director of Clinical Operations - Joel Hix

We are happy to introduce Joel Hix, Director of Clinical Operations at CLS Americas. Joel has over 15 years of senior management experience in operations, sales, marketing, and service with leading medical device manufacturers including Boston Scientific and Healthtronics.

Read more

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!

Please choose your country or region